Conference abstract
Conference abstractPublished 23 Nov 2012
Complimentary approaches to metabolic syndrome: Opportunities and challenges
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Metabolic syndrome has become a worldwide health problem as it affects more than one third of the population and it sets the stage for catastrophic health problems, such as hyperglycemia, high blood pressure, dyslipidaemia, heart disease, and other age-related diseases. But as a matter of fact, till date in modern medicine there has not been a single drug molecule to mitigate these interrelated states of multiple disorders. Although Diet, exercise, and nutritional supplementation play a key role in its prevention and treatment but it is difficult for patients to follow a diet/exercise regime that would improve their symptoms therefore natural products identified from traditional medicinal plants present an exciting opportunity for the treatment of metabolic syndrome because they contain a wide range of phytochemicals with diverse metabolic effects. We have discovered following plants which were found to be of significant importance such as Lagenaria siceraria with Trigonella foenum graecum for hyperlipidemia, Curcuma longa with piper nigrum and Allium cepa in the treatment of glucose tolerance associated with excess dietary fat intake, obesity and type 2 diabetes due to better safety, tolerability and increased healthcare costs with conventional pharmaceuticals. Globally,, with the advancement of modern medicine there has been a tremendous shift in expanding the horizons of availability of medications from traditional herbs as it has significant potential to deliver next generation medicines for metabolic syndrome with the ultimate goal of maximizing the opportunities and overcoming the challenges.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Review article · 3 May 2019
Innovative approaches for nasal drug delivery system and its challenges and opportunities
Conference abstract · 8 Dec 2014
In silico approach to predict ADME-Tox properties of small organic molecules: Challenges and opportunities for drug discovery
Conference abstract · 18 Sep 2020
Botanical Asteraceae hydroxy-cinnamic acid derivatives a Pharmacognostical approach to delay the metabolic syndrome progression
Commentary · 2013
MYC, Metabolism and Malignancy: Opportunities for Therapeutic Intervention
More from this journal
The newest in Pharmaceutical Regulatory Affairs: Open Access.
Article · 13 Feb 2026
Regulatory Scenario of Pharmaceuticals during COVID-19 Pandemic in India
Article · 11 Feb 2026
EU GMP Annex 1 of 2022: A View in Depth
Article · 11 Feb 2026
Standard Formats Used in Drug Regulatory Submissions and Software Used
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalPharmaceutical Regulatory Affairs: Open Access
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Ginpreet Kaur”

